Liminatus Pharma, Inc..
LIMN.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Liminatus Pharma, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for the treatment of unmet medical needs. The company's pipeline includes drug candidates targeting various diseases. Liminatus Pharma utilizes its research and de...Show More
Better Health for All
40
Liminatus Pharma is a biopharmaceutical company focused on developing novel therapeutics and diagnostics for unmet medical needs, such as cancer. The company has no reported revenue from products with established negative health outcomes, as its focus is on developing health-positive offerings.
1
In 2024, Liminatus Pharma's research and development expenses were $2.7 million, and in 2023, they were $3.8 million.
2
These R&D expenses represent 100% of the company's reported operational expenditure, indicating a complete allocation to health improvement. The company is developing a blood-based diagnostic kit for early pancreatic cancer detection, which demonstrated over 90-98% sensitivity and over 99% specificity in a cohort of 1,086 subjects.
3
This diagnostic tool aims to improve early detection, aligning with preventative health measures.
Fair Money & Economic Opportunity
0
Liminatus Pharma, Inc. is a biopharmaceutical company focused on therapeutics.
1
The provided articles contain no evidence that the company operates as a financial institution, offers lending or deposit services to consumers, or engages in any activities related to financial inclusion or economic opportunity for underserved populations. Therefore, all KPIs related to fair money and economic opportunity are scored as 'Not applicable' or 'No direct impact' as the company's core business lies outside financial services.
Fair Pay & Worker Respect
0
No evidence available to assess Liminatus Pharma, Inc. on Fair Pay & Worker Respect.
Fair Trade & Ethical Sourcing
0
No relevant data was found in the provided articles to assess Liminatus Pharma, Inc. against the Fair Trade & Ethical Sourcing value.
1
All articles explicitly stated that no information pertaining to the company or the specified ethical sourcing metrics could be extracted.
2
Honest & Fair Business
0
No evidence available to assess Liminatus Pharma, Inc. on Honest & Fair Business.
Kind to Animals
0
No specific, concrete data points were found in the provided articles regarding Liminatus Pharma, Inc.'s performance against any of the 'Kind to Animals' KPIs. The articles discuss general industry trends, regulatory changes by the FDA, and advocacy efforts by other organizations, but do not provide company-specific information on animal testing volumes, policies, use of alternative methods, certifications, or conservation impacts for Liminatus Pharma, Inc.
1
No War, No Weapons
0
No evidence available to assess Liminatus Pharma, Inc. on No War, No Weapons.
Planet-Friendly Business
0
No sustainability data is available for Liminatus Pharma, Inc. in the provided article, preventing assessment against any of the Planet-Friendly Business KPIs.
1
Respect for Cultures & Communities
0
No evidence available to assess Liminatus Pharma, Inc. on Respect for Cultures & Communities.
Safe & Smart Tech
0
No information regarding data protection, cybersecurity, or responsible AI practices for Liminatus Pharma, Inc. was found in the provided article.
1
The article focuses on the company's merger and financial details.
2
Zero Waste & Sustainable Products
0
No specific, concrete evidence was found in the provided articles regarding Liminatus Pharma, Inc.'s performance across any of the 'Zero Waste & Sustainable Products' KPIs. The articles either did not mention the company, or explicitly stated that no relevant information was present concerning waste diversion, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design, waste reduction initiatives, hazardous waste management, product durability, repairability, waste audits, zero waste certification, waste disposal violations, material efficiency, packaging-to-product ratio, waste reduction targets, supplier waste requirements, or customer waste education.
1